BR100 Increased By (0.36%)
BR30 Decreased By (-0.13%)
KSE100 Increased By (0.22%)
KSE30 Increased By (0.37%)
AGHA 6.68 Increased By ▲ 0.01 (0.15%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 57.32 Increased By ▲ 0.88 (1.56%)
BOP 30.35 Increased By ▲ 0.01 (0.03%)
CNERGY 13.12 Increased By ▲ 0.03 (0.23%)
CSIL 5.41 Increased By ▲ 0.05 (0.93%)
FCCL 52.79 Increased By ▲ 0.41 (0.78%)
FFL 14.72 Decreased By ▼ -0.02 (-0.14%)
FNEL 1.12 No Change ▼ 0.00 (0%)
KEL 6.09 No Change ▼ 0.00 (0%)
KOSM 5.73 Increased By ▲ 0.77 (15.52%)
LOTCHEM 26.46 Decreased By ▼ -0.89 (-3.25%)
MLCF 93.16 Increased By ▲ 0.41 (0.44%)
NBP 164.66 Decreased By ▼ -0.32 (-0.19%)
NCPL 55.66 Increased By ▲ 0.02 (0.04%)
NPL 61.16 Decreased By ▼ -0.10 (-0.16%)
OGDC 316.73 Decreased By ▼ -1.03 (-0.32%)
PACE 9.87 Decreased By ▼ -0.06 (-0.6%)
PAEL 35.63 Increased By ▲ 0.13 (0.37%)
PIBTL 14.68 Increased By ▲ 0.11 (0.75%)
PPL 226.91 Decreased By ▼ -0.88 (-0.39%)
PRL 93.02 Increased By ▲ 0.45 (0.49%)
PTC 60.26 Decreased By ▼ -0.37 (-0.61%)
SSGC 23.81 Increased By ▲ 0.01 (0.04%)
TBL 8.75 Increased By ▲ 0.07 (0.81%)
TELE 7.80 Increased By ▲ 0.02 (0.26%)
TPL 22.35 Increased By ▲ 0.12 (0.54%)
TPLP 12.97 Increased By ▲ 0.30 (2.37%)
TREET 22.16 Decreased By ▼ -0.38 (-1.69%)
TRG 56.56 Decreased By ▼ -1.24 (-2.15%)
اردو
Android App
Print Edition Dollar to PKR
Daily Petrol Prices Intl Oil Prices Iran-US war Gold Rates Podcasts PSX Notices
Topic

Oxford vaccine

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s

Published 07 Apr, 2021 08:09pm
  • "We are not advising a stop to any vaccination for any individual in any age group. We are advising a preference for one vaccine over another vaccine for a particular age group, really out of the utmost caution, rather than because we have any serious safety concerns," he said at a briefing. It came after Britain's MHRA medicine regulator identified a possible side-effect from the COVID-19 vaccine developed by Oxford University and AstraZeneca involving rare brain blood clotting.
AstraZeneca/Oxford vaccine more effective with longer dose gap: study

AstraZeneca/Oxford vaccine more effective with longer dose gap: study

Published 19 Feb, 2021 09:17pm
  • The study confirmed the Anglo-Swedish drugmaker's findings from earlier this month that showed the vaccine had 76% efficacy against symptomatic coronavirus infection for three months after the first dose.
  • Efficacy was found to be at 81% with the longer interval of 12 weeks between the first and second dose, compared with 55% efficacy up to the six-week gap.
South Africa offers AstraZeneca jabs to AU

South Africa offers AstraZeneca jabs to AU

Published 17 Feb, 2021 11:06am
  • "The first batch of Johnson & Johnson Covid-19 vaccines have arrived at OR Tambo International Airport," Mkhize tweeted as the precious cargo landed in the financial capital Johannesburg.
Different age rules for Oxford/AstraZeneca COVID-19 vaccine in EU

Different age rules for Oxford/AstraZeneca COVID-19 vaccine in EU

Published 08 Feb, 2021 08:32pm
  • Some EU countries, though, have limited its use to people under 65 because of a lack of data for older people in clinical trials for the shot.
  • Countries that have recommended the vaccine's use for people between 18 and 64 years old:
Oxford says COVID-19 vaccine with AstraZeneca works against UK variant

Oxford says COVID-19 vaccine with AstraZeneca works against UK variant

Published 05 Feb, 2021 07:38pm
  • Britain had said that it believed the vaccines were effective against variants that are circulating in the UK.
  • Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus.
Loading...